Viewing Study NCT03560713



Ignite Creation Date: 2024-05-06 @ 11:37 AM
Last Modification Date: 2024-10-26 @ 12:47 PM
Study NCT ID: NCT03560713
Status: COMPLETED
Last Update Posted: 2020-03-25
First Post: 2018-05-24

Brief Title: Effects of Functional Electrical Stimulation in Patients Undergoing Coronary Artery Bypass Grafting Surgery
Sponsor: Universidade Federal de Santa Maria
Organization: Universidade Federal de Santa Maria

Study Overview

Official Title: Effects of Functional Electrical Stimulation in Patients Undergoing Coronary Artery Bypass Grafting Surgery
Status: COMPLETED
Status Verified Date: 2020-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Even with major advances in clinical therapy and percutaneous interventions coronary artery bypass grafting CABG is the most common cardiac surgery performed worldwide and is an effective treatment in reducing symptoms and mortality in patients with coronary artery disease CAD However CABG is a complex procedure that triggers a series of clinical and functional complications such as series postoperative repercussions as muscle wasting in the first four hours after surgery For quantification of changes in muscle structure and morphology ultrasonography has been used

In this context cardiac rehabilitation program CRP is an essential component of care in CABG patients because this intervention can prevent muscle weakness and wasting Among different treatment modalities functional electrical stimulation FES is a feasible therapy for neuromuscular activation and prevent muscle weakness and wasting in patients in phase I CRP however the effect of this intervention in phase II CRP not been fully elucidated The purpose of this study will to assess the effects of FES plus combined aerobic and resistance training on muscle thickness of quadriceps femoris lower limbs muscle strength functional capacity QoL in in CABG patients enrolled in a phase II CR program
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None